| Therapeutic Trauma And Counseling | |
|
517 La Paz Ave Bismarck ND 58503-9097 | |
| (701) 595-2414 | |
| Not Available |
| Full Name | Therapeutic Trauma And Counseling |
|---|---|
| Speciality | Social Worker |
| Location | 517 La Paz Ave, Bismarck, North Dakota |
| Authorized Official Name and Position | Jennifer A Lefever (OWNER) |
| Authorized Official Contact | 7015952414 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Therapeutic Trauma And Counseling Po Box 111 Bismarck ND 58502-0111 Ph: () - | Therapeutic Trauma And Counseling 517 La Paz Ave Bismarck ND 58503-9097 Ph: (701) 595-2414 |
| NPI Number | 1093305294 |
|---|---|
| Provider Enumeration Date | 01/21/2021 |
| Last Update Date | 01/21/2021 |
| Certification Date | 01/21/2021 |
| Medicare PECOS PAC ID | 1658724711 |
|---|---|
| Medicare Enrollment ID | O20240125001923 |
News Archive
Knowledge of the facts is called factive knowledge. In the phrase "He knows [that it is warm outside]", the embedded clause is assumed to be true.
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics' common shares.
CTI BioPharma Corp. and Baxter International Inc. today announced that data from the randomized Phase 3 PERSIST-1 trial evaluating the investigational agent pacritinib in patients with myelofibrosis will be highlighted in a late-breaking oral presentation at the upcoming American Society of Clinical Oncology 2015 Meeting (May 29-June 2, 2015 in Chicago, Ill).
Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPin® sales (the "Re-Revised Proposal").
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093305294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Jennifer A Lefever |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1518347707 PECOS PAC ID: 1557621687 Enrollment ID: I20180208002994 |
News Archive
Knowledge of the facts is called factive knowledge. In the phrase "He knows [that it is warm outside]", the embedded clause is assumed to be true.
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics' common shares.
CTI BioPharma Corp. and Baxter International Inc. today announced that data from the randomized Phase 3 PERSIST-1 trial evaluating the investigational agent pacritinib in patients with myelofibrosis will be highlighted in a late-breaking oral presentation at the upcoming American Society of Clinical Oncology 2015 Meeting (May 29-June 2, 2015 in Chicago, Ill).
Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPin® sales (the "Re-Revised Proposal").
› Verified 5 days ago
News Archive
Knowledge of the facts is called factive knowledge. In the phrase "He knows [that it is warm outside]", the embedded clause is assumed to be true.
Biologists at the University of Oslo, Norway, are now making a giant effort to identify the relationship between climate change, rat infestations, and the many major plague epidemics throughout history. The knowledge may be used to predict the next plague outbreak.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the signing of a Letter of Intent (LOI) with Lanzhou New Sunshine Plastics Industry LTD. This expected acquisition is the fourth planned acquisition targeted at a share price of US $1.50 for Biomagnetics Diagnostics' common shares.
CTI BioPharma Corp. and Baxter International Inc. today announced that data from the randomized Phase 3 PERSIST-1 trial evaluating the investigational agent pacritinib in patients with myelofibrosis will be highlighted in a late-breaking oral presentation at the upcoming American Society of Clinical Oncology 2015 Meeting (May 29-June 2, 2015 in Chicago, Ill).
Allergan, Inc. ("Allergan" or the "Company") today acknowledged that Valeant Pharmaceuticals International, Inc. ("Valeant") and Pershing Square Capital Management, L.P. ("Pershing Square") have made a second revised, unsolicited proposal to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant common shares, $72.00 in cash per share of common stock of the Company, and a Contingent Value Right (CVR) related to DARPin® sales (the "Re-Revised Proposal").
› Verified 5 days ago
Missouri River Health Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 425 E Avenue C, Bismarck, ND 58501 Phone: 701-712-9962 | |
Telehealth Physician Network, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 S 2nd St Ste 155, Bismarck, ND 58504 Phone: 833-484-6359 | |
Beacon Counseling Services Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4205 State St Ste 5, Bismarck, ND 58503 Phone: 701-214-5530 Fax: 701-712-5587 | |
Whole Person Recovery Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1138 Summit Boulevard, Bismarck, ND 58504 Phone: 701-224-1261 | |
Thrive Child & Family Therapy Center Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 E Main Ave Ste 102, Bismarck, ND 58501 Phone: 701-989-0210 | |
Adapt, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1720 Burnt Boat Drive, Suite 108, Bismarck, ND 58503 Phone: 701-255-3717 |